Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
86.35
+3.39 (4.09%)
Dec 4, 2025, 4:00 PM EST - Market closed
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $1.26 billion as of December 5, 2025. Its market cap has increased by 527.29% in one year.
Market Cap
1.26B
Enterprise Value
1.23B
1-Year Change
527.29%
Ranking
Category
Stock Price
$86.35
Market Cap Chart
Since the IPO on May 29, 2024, Inhibrx Biosciences's market cap has increased from $198.24M to $1.26B, an increase of 533.51%. That is a compound annual growth rate of 238.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 1.21B | 441.23% |
| Dec 31, 2024 | 222.93M | 12.46% |
| May 29, 2024 | 198.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.68B |
| Johnson & Johnson | 494.92B |
| AbbVie | 396.55B |
| UnitedHealth Group | 293.98B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.76B |
| Abbott Laboratories | 219.65B |